RPHM Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 146096 min ago

@ $1.715

Wydano: 9 vas. 2024 @ 18:54

Zwrot: 10.79%

Poprzedni sygnał: vas. 9 - 17:42

Poprzedni sygnał: Sprzedaż

Zwrot: 0.42 %

Live Chart Being Loaded With Signals

Commentary (20 geg. 2024 @ 23:00):

Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases...

Stats
Dzisiejszy wolumen	274 714
Średni wolumen	278 300
Kapitalizacja rynkowa	63.50M
EPS	$0 ( 2024-05-09 )
Następna data zysków	( $-0.170 ) 2024-08-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.880
ATR14	$0.00400 (0.21%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-14	Leonard Braden Michael	Buy	335 000	Common Stock
2024-05-14	Leonard Braden Michael	Buy	79 281	Common Stock
2024-05-14	Leonard Braden Michael	Buy	0	Common Stock
2024-05-14	Leonard Braden Michael	Sell	0	Common Stock
2023-08-28	Hall Ashley	Sell	15 625	Stock option (right to buy)

INSIDER POWER
71.20
Last 94 transactions
Buy: 16 229 361 \| Sell: 47 287 756

Wolumen Korelacja

Długi: 0.04 (neutral)

Krótki: 0.74 (moderate)

Signal:(49.088) Neutral

Reneo Pharmaceuticals, Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Reneo Pharmaceuticals, Korelacja - Waluta/Towar

0.87
( strong )

0.91
( very strong )

0.00
( neutral )

0.89
( strong )

0.00
( neutral )

0.23
( neutral )

Reneo Pharmaceuticals, Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$-525 000 (0.00 %)
EPS:	$-2.52

FY	2023
Przychody:	$0
Zysk brutto:	$-525 000 (0.00 %)
EPS:	$-2.52

FY	2022
Przychody:	$0
Zysk brutto:	$-529 000 (0.00 %)
EPS:	$-2.04

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-5.11

Financial Reports:

No articles found.

Reneo Pharmaceuticals, Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Reneo Pharmaceuticals,

Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as well as in Phase 1b clinical trial in patients with long-chain fatty acid oxidation disorders and glycogen storage disease type V. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in San Diego, California.